Document is current
Any future updates will be listed below
-
Authors
Zheng, Shan
Lin, Rong
Chen, Shaoming
Zheng, Jieling
Lin, Zefang
Zhang, Ying
Xue, Qianqian
Chen, Yun
Zhang, Jiaying
Lin, Kaixian
You, Xin
Yao, Shaobo
Miao, Weibing https://orcid.org/0000-0002-0058-4953
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04499365 at ClinicalTrials.govDocuments that mention this clinical trial
Characterization of the benign lesions with increased 68Ga-FAPI-04 uptake in PET/CT
https://doi.org/10.1007/s12149-021-01673-w
68Ga-DOTA-FAPI-04 PET/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients
https://doi.org/10.1007/s12149-022-01742-8
-
Funding
Funding for this research was provided by:
national natural science foundation of china (81971651)
Natural Science Foundation of Fujian Province (2019J01454)
Natural Science Foundation of Fujian Province (2020J05249)
Fujian Provincial Health Commission Science and Technology and Programme (2020GGA045)
Fujian Provincial Health and Family Planning Youth Scientific Research Project (2018-2-21)
- License Information
-
More Information
Article History
Received: 29 April 2021
Accepted: 18 August 2021
First Online: 23 August 2021
Declarations
:
: The authors declare that they have no conflict of interest.
: The study was approved by the institutional review board of our hospital and written informed consent for publication of this report was obtained from the patients.
